HEATHER MOREIRA: Open Payments
NPI 1922630144 · NEW BRUNSWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$398 in 18 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $152 · 2025 $398
Food & beverage: $347Education: $51
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 6 | $145 |
| Janssen Biotech, Inc. | 3 | $94 |
| QOL Medical, LLC | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
| Ardelyx, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
Products named: REZDIFFRA, TREMFYA, Sucraid, ENTYVIO, IBSRELA, VOQUEZNA, OMVOH.
Industry payments across NJ — which companies pay providers there.
